Versant Venture Management, LLC Portfolio Holdings

Versant Venture Management, LLC has filed its 13F form on May 07, 2025 for Q1 2025 where it was disclosed a total value porftolio of $48 Million distributed in 7 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Monte Rosa Therapeutics, Inc. with a value of $26.2M, Crispr Therapeutics Ag with a value of $17M, Repare Therapeutics Inc. with a value of $2.62M, Adverum Biotechnologies, Inc. with a value of $2.21M, and Contineum Therapeutics, Inc. with a value of $0.

Examining the 13F form we can see an decrease of $19.6M in the current position value, from $67.6M to 48M.

Versant Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about Versant Venture Management, LLC portfolio as well as his latest detailed transactions.